KRAS and malignant colon neoplasm: In another study in colorectal cancel model, [128,129] authors founded that PCSK9 induces oncogenesis in APC/KRAS mutant models of colon cancer and that systemic PCSK9 levels correlate with reduced survival in this patient cohort.